Skip to main content
Genomics Working PartyGenomics Working Party Archive

Leveraging partnerships to realise the UK’s potential in genomics

BIVDA has commissioned a report with Charles Rivers Associates to look at the role of partnerships and policy solutions in addressing challenges in the genomics diagnostics landscape. The objective was to develop a novel, evidence-based industry report supporting the wider implementation of genomic testing to address the following questions; What value does genomic testing bring to patients, physicians, health systems,…
Ben Kemp
March 3, 2023
HighlightsHighlights Archive

Media Monitoring: 25th February – 3rd March

Wes Streeting: Labour’s reforms will save the struggling NHS from its current crisis The Shadow Health Secretary has pledged to Labour will double medical school places, paid for by abolishing non-doms He also wants to cut unnecessary appointments through better access to specialist clinics, akin to sexual health clinics, to free up GP appointments   NHS COVID-19 app saved estimated…
Ben Kemp
March 3, 2023
HighlightsHighlights Archive

Bowel cancer survivors offered pioneering blood tests

200 bowel cancer survivors in Swansea are to be offered revolutionary blood tests to check whether their disease has returned. Those chosen will also be on a waiting list for colonoscopies, ensuring a diagnosis is not delayed if indeed a patient’s cancer has reappeared and offering peace of mind for those who are cleared. The rollout has been funded by…
Ben Kemp
March 3, 2023
HighlightsHighlights Archive

Scientists hopeful of Horizon Europe association following the Windsor Framework

Scientists remain hopeful that the UK’s reassociation with Horizon Europe may now be achieved following the Northern Ireland ‘Windsor Framework’ deal and a warming of UK-EU relations. For over two years, talks have been put on hold due to Brexit trade deal negotiations and UK scientists barely benefitted from the £88.8bn programme. This has already impacted UK scientists’ ability to…
Ben Kemp
March 3, 2023